Cargando…
Glycyrrhizic acid derivatives as Dengue virus inhibitors
Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172207/ https://www.ncbi.nlm.nih.gov/pubmed/31519375 http://dx.doi.org/10.1016/j.bmcl.2019.126645 |
_version_ | 1783524211607732224 |
---|---|
author | Baltina, Lidia A. Tasi, Yan-Ting Huang, Su-Hua Lai, Hsueh-Chou Baltina, Lia A. Petrova, Svetlana F. Yunusov, Marat S. Lin, Cheng-Wen |
author_facet | Baltina, Lidia A. Tasi, Yan-Ting Huang, Su-Hua Lai, Hsueh-Chou Baltina, Lia A. Petrova, Svetlana F. Yunusov, Marat S. Lin, Cheng-Wen |
author_sort | Baltina, Lidia A. |
collection | PubMed |
description | Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection. |
format | Online Article Text |
id | pubmed-7172207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71722072020-04-22 Glycyrrhizic acid derivatives as Dengue virus inhibitors Baltina, Lidia A. Tasi, Yan-Ting Huang, Su-Hua Lai, Hsueh-Chou Baltina, Lia A. Petrova, Svetlana F. Yunusov, Marat S. Lin, Cheng-Wen Bioorg Med Chem Lett Article Dengue virus (DENV) is one of the most geographically distributed pathogenic flaviviruses transmitted by mosquitoes Aedes sps. In this study, the structure-antiviral activity relationships of Glycyrrhizic acid (GL) derivatives was evaluated by the inhibitory assays on the cytopathic effect (CPE) and viral infectivity of DENV type 2 (DENV2) in Vero E6 cells. GL (96% purity) had a low cytotoxicity to Vero E6 cells, inhibited DENV2-induced CPE, and reduced the DENV-2 infectivity with the IC50 of 8.1 μM. Conjugation of GL with amino acids or their methyl esters and the introduction of aromatic acylhydrazide residues into the carbohydrate part strongly influenced on the antiviral activity. Among compounds tested GL conjugates with isoleucine 13 and 11-aminoundecanoic acid 17 were found as potent anti-DENV2 inhibitors (IC50 1.2–1.3 μM). Therefore, modification of GL is a perspective way in the search of new antivirals against DENV2 infection. Elsevier Ltd. 2019-10-15 2019-08-29 /pmc/articles/PMC7172207/ /pubmed/31519375 http://dx.doi.org/10.1016/j.bmcl.2019.126645 Text en © 2019 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Baltina, Lidia A. Tasi, Yan-Ting Huang, Su-Hua Lai, Hsueh-Chou Baltina, Lia A. Petrova, Svetlana F. Yunusov, Marat S. Lin, Cheng-Wen Glycyrrhizic acid derivatives as Dengue virus inhibitors |
title | Glycyrrhizic acid derivatives as Dengue virus inhibitors |
title_full | Glycyrrhizic acid derivatives as Dengue virus inhibitors |
title_fullStr | Glycyrrhizic acid derivatives as Dengue virus inhibitors |
title_full_unstemmed | Glycyrrhizic acid derivatives as Dengue virus inhibitors |
title_short | Glycyrrhizic acid derivatives as Dengue virus inhibitors |
title_sort | glycyrrhizic acid derivatives as dengue virus inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172207/ https://www.ncbi.nlm.nih.gov/pubmed/31519375 http://dx.doi.org/10.1016/j.bmcl.2019.126645 |
work_keys_str_mv | AT baltinalidiaa glycyrrhizicacidderivativesasdenguevirusinhibitors AT tasiyanting glycyrrhizicacidderivativesasdenguevirusinhibitors AT huangsuhua glycyrrhizicacidderivativesasdenguevirusinhibitors AT laihsuehchou glycyrrhizicacidderivativesasdenguevirusinhibitors AT baltinaliaa glycyrrhizicacidderivativesasdenguevirusinhibitors AT petrovasvetlanaf glycyrrhizicacidderivativesasdenguevirusinhibitors AT yunusovmarats glycyrrhizicacidderivativesasdenguevirusinhibitors AT linchengwen glycyrrhizicacidderivativesasdenguevirusinhibitors |